Early Psoriatic Arthritis

Rheumatic Disease Clinics of North America

Volumn 41, Issue 4, 2015, Pages 615-622

  McHugh, Neil John ^a  

^a University of Bath   (United Kingdom)

Author keywords

Biomarkers; Genetic screening; Psoriasis; Psoriatic arthritis

Indexed keywords

COLLAGEN TYPE 2; COLONY STIMULATING FACTOR 1; DICKKOPF 1 PROTEIN; HLA B27 ANTIGEN; OSTEOPROTEGERIN; STROMELYSIN;

COMORBIDITY; DELAYED DIAGNOSIS; DIAGNOSTIC IMAGING; ENTHESITIS; GENETIC SUSCEPTIBILITY; HUMAN; LOW BACK PAIN; NAIL PSORIASIS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; REVIEW; RISK FACTOR; SCREENING TEST; ARTHRITIS, PSORIATIC; EARLY DIAGNOSIS; GENETIC SCREENING; PROCEDURES;

ARTHRITIS, PSORIATIC; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; GENETIC TESTING; HUMANS;

EID: 84945482476     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2015.07.005     Document Type: Review

References (44)

1. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008, 35(7):1354-1358.
2. Hoff M., Gulati A.M., Romundstad P.R., et al. Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Trondelag Health Study (HUNT). Ann Rheum Dis 2015, 74(1):60-64.
3. Wilson F.C., Icen M., Crowson C.S., et al. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009, 61(2):233-239.
4. Eder L., Chandran V., Shen H., et al. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res 2011, 63(4):619-622.
5. Henes J.C., Ziupa E., Eisfelder M., et al. High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study. Rheumatol Int 2014, 34(2):227-234.
6. Haroon M., Kirby B., FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis 2013, 72(5):736-740.
7. Reich K., Kruger K., Mossner R., et al. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 2009, 160(5):1040-1047.
8. Mease P.J., Gladman D.D., Papp K.A., et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2013, 69(5):729-735.
9. Lebwohl M.G., Bachelez H., Barker J., et al. Patient perspectives in the management of psoriasis: results from the population-based multinational assessment of psoriasis and psoriatic arthritis survey. J Am Acad Dermatol 2014, 70(5):871-881.e30.
10. Husted J.A., Gladman D.D., Farewell V.T., et al. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001, 45(2):151-158.
11. Kane D., Stafford L., Bresnihan B., et al. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology 2003, 42(12):1460-1468.
12. McHugh N.J., Balachrishnan C., Jones S.M. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology 2003, 42(6):778-783.
13. Gladman D.D., Thavaneswaran A., Chandran V., et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease?. Ann Rheum Dis 2011, 70(12):2152-2154.
14. Tillett W., Jadon D., Shaddick G., et al. Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritis. Ann Rheum Dis 2013, 72(8):1358-1361.
15. Haroon M., Gallagher P., Fitzgerald O. Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. Ann Rheum Dis 2015, 74(6):1045-1050.
16. Theander E., Husmark T., Alenius G.M., et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis 2014, 73(2):407-413.
17. Kirkham B., de Vlam K., Li W., et al. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Clin Exp Rheumatol 2015, 33(1):11-19.
18. Taylor W., Gladman D., Helliwell P., et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54(8):2665-2673.
19. Chandran V., Schentag C.T., Gladman D.D. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007, 57(8):1560-1563.
20. Coates L.C., Aslam T., Al Balushi F., et al. Comparison of three screening tools to detect psoriatic arthritis in patients with psoriasis (CONTEST study). Br J Dermatol 2013, 168(4):802-807.
21. Mease P.J., Gladman D.D., Helliwell P., et al. Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol 2014, 71(4):649-655.
22. Coates L.C., Walsh J., Haroon M., et al. Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res 2014, 66(9):1410-1416.
23. Gisondi P., Tinazzi I., El-Dalati G., et al. Lower limb enthesopathy in patients with psoriasis without clinical signs of arthropathy: a hospital-based case-control study. Ann Rheum Dis 2008, 67(1):26-30.
24. Aydin S.Z., Ash Z.R., Tinazzi I., et al. The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. Ann Rheum Dis 2013, 72(6):992-995.
25. Ash Z.R., Tinazzi I., Gallego C.C., et al. Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. Ann Rheum Dis 2012, 71(4):553-556.
26. Emad Y., Ragab Y., Gheita T., et al. Knee enthesitis and synovitis on magnetic resonance imaging in patients with psoriasis without arthritic symptoms. J Rheumatol 2012, 39(10):1979-1986.
27. El Miedany Y., El Gaafary M., Youssef S., et al. Tailored approach to early psoriatic arthritis patients: clinical and ultrasonographic predictors for structural joint damage. Clin Rheumatol 2015, 34(2):307-313.
28. Langenbruch A., Radtke M.A., Krensel M., et al. Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis. Br J Dermatol 2014, 171(5):1123-1128.
29. Li W., Han J., Qureshi A.A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis 2012, 71(6):804-808.
30. Eder L., Shanmugarajah S., Thavaneswaran A., et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis 2012, 71(2):219-224.
31. Love T.J., Zhu Y., Zhang Y., et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis 2012, 71(8):1273-1277.
32. Rouzaud M., Sevrain M., Villani A.P., et al. Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol 2014, 28(Suppl 5):17-26.
33. Christophers E., Barker J.N., Griffiths C.E., et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol 2010, 24(5):548-554.
34. Winchester R., Minevich G., Steshenko V., et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 2012, 64(4):1134-1144.
35. Bowes J., Eyre S., Flynn E., et al. Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris. Ann Rheum Dis 2011, 70(6):1016-1019.
36. Haroon M., Winchester R., Giles J.T., et al. Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype. Ann Rheum Dis 2014, [Epub ahead of print].
37. Ritchlin C. Biomarker development in psoriatic arthritis. J Rheumatol Suppl 2012, 89:57-60.
38. Jadon D.R., Nightingale A.L., McHugh N.J., et al. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol 2015, 42(1):21-30.
39. Chandran V. Soluble biomarkers may differentiate psoriasis from psoriatic arthritis. J Rheumatol Suppl 2012, 89:65-66.
40. Jones S.M., Armas J.B., Cohen M.G., et al. Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 1994, 33(9):834-839.
41. Caso F., Costa L., Atteno M., et al. Simple clinical indicators for early psoriatic arthritis detection. Springerplus 2014, 3:759.
42. Tillett W., McHugh N. Treatment algorithms for early psoriatic arthritis: do they depend on disease phenotype?. Curr Rheumatol Rep 2012, 14(4):334-342.
43. Poole C.D., Lebmeier M., Ara R., et al. Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK. Rheumatology 2010, 49(10):1949-1956.
44. Tillett W., Shaddick G., Askari A., et al. Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study. Rheumatology 2015, 54(1):157-162.